These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32110065)
1. Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Esfahani S; Ahmadrajabi R; Mollaei H; Saffari F Infect Drug Resist; 2020; 13():553-559. PubMed ID: 32110065 [TBL] [Abstract][Full Text] [Related]
2. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study. Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598 [TBL] [Abstract][Full Text] [Related]
3. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates. Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458 [TBL] [Abstract][Full Text] [Related]
4. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs. Kotb DN; Mahdy WK; Mahmoud MS; Khairy RMM BMC Infect Dis; 2019 Nov; 19(1):979. PubMed ID: 31752702 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of fluoroquinolone-resistant Escherichia coli strains isolated from urine clinical samples. Dehbanipour R; Khanahmad H; Sedighi M; Bialvaei AZ; Faghri J J Prev Med Hyg; 2019 Mar; 60(1):E25-E30. PubMed ID: 31041407 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from Brazil. Minarini LA; Darini AL Braz J Microbiol; 2012 Oct; 43(4):1309-14. PubMed ID: 24031957 [TBL] [Abstract][Full Text] [Related]
7. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China. Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of efrAB efflux pump among Enterococcus faecalis ST480, ST847 in Iran. Shiadeh SMJ; Azimi L; Azimi T; Pourmohammad A; Goudarzi M; Chaboki BG; Hashemi A Acta Microbiol Immunol Hung; 2020 Sep; 67(3):187-192. PubMed ID: 32986605 [TBL] [Abstract][Full Text] [Related]
9. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland. Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the Nguyen KV; Nguyen TV; Nguyen HTT; Le DV Infect Drug Resist; 2018; 11():275-282. PubMed ID: 29535543 [TBL] [Abstract][Full Text] [Related]
11. Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China. Zhan Q; Xu Y; Wang B; Yu J; Shen X; Liu L; Cao X; Guo Y; Yu F BMC Microbiol; 2021 Jun; 21(1):164. PubMed ID: 34078263 [TBL] [Abstract][Full Text] [Related]
12. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci. Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527 [TBL] [Abstract][Full Text] [Related]
13. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166 [TBL] [Abstract][Full Text] [Related]
14. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran. Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930 [TBL] [Abstract][Full Text] [Related]
16. Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii. Park S; Lee KM; Yoo YS; Yoo JS; Yoo JI; Kim HS; Lee YS; Chung GT Osong Public Health Res Perspect; 2011 Dec; 2(3):164-70. PubMed ID: 24159468 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance assessment and multi-drug efflux pumps of Enterococcus faecium isolated from clinical specimens. Mirzaii M; Alebouyeh M; Sohrabi MB; Eslami P; Fazli M; Ebrahimi M; HajiAsgarli P; Rashidan M J Infect Dev Ctries; 2023 May; 17(5):649-655. PubMed ID: 37279423 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Farahi RM; Ali AA; Gharavi S Iran J Microbiol; 2018 Aug; 10(4):242-249. PubMed ID: 30483376 [TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance and mutation patterns in gyrA and parC genes in Neisseria gonorrhoeae isolates from Shanghai, China. Zhang T; Zhou X; Chen Y; Gu W; Zhang T; Jiang Q J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):29-34. PubMed ID: 19224158 [TBL] [Abstract][Full Text] [Related]
20. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Jia W; Wang J; Xu H; Li G Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]